Bluejay Diagnostics, Inc.
BJDX
$1.47
$0.021.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.94M | 3.71M | 3.70M | 3.87M | 4.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.72M | 6.63M | 7.17M | 8.07M | 9.05M |
| Operating Income | -6.72M | -6.63M | -7.17M | -8.07M | -9.05M |
| Income Before Tax | -6.74M | -7.25M | -7.72M | -8.59M | -9.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.74 | -7.25 | -7.72 | -8.59 | -9.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.74M | -7.25M | -7.72M | -8.59M | -9.40M |
| EBIT | -6.72M | -6.63M | -7.17M | -8.07M | -9.05M |
| EBITDA | -6.65M | -6.56M | -7.09M | -7.99M | -8.74M |
| EPS Basic | -40.34 | -38.93 | -35.57 | -7.75 | -- |
| Normalized Basic EPS | -9.53 | -8.65 | -6.55 | -4.85 | -- |
| EPS Diluted | -40.34 | -38.93 | -35.57 | -7.75 | -- |
| Normalized Diluted EPS | -9.53 | -8.65 | -6.55 | -4.85 | -- |
| Average Basic Shares Outstanding | 2.66M | 1.27M | 718.00K | 191.10K | -- |
| Average Diluted Shares Outstanding | 2.66M | 1.27M | 718.00K | 191.10K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |